Literature DB >> 21840245

Expression and mutation analysis of heterogeneous nuclear ribonucleoprotein G in human oral cancer.

Ki-Hyuk Shin1, Reuben H Kim, Bo Yu, Mo K Kang, David Elashoff, Russell Christensen, Ana Pucar, No-Hee Park.   

Abstract

We previously reported that wild type (wt) hnRNP G exhibited tumor suppressive activity in human oral squamous cell carcinoma (HOSCC) cell lines lacking hnRNP G. Wt hnRNP G markedly inhibited the proliferation capacity, anchorage independency and in vivo tumorigenicity of HOSCC cells and notably enhanced the DNA repair capabilities of these cells. In the present study, we studied the genetic and expression states of hnRNP G in normal, premalignant and malignant human oral tissues to further understand the relationship between the hnRNP G alterations and the development of human oral cancer. To correlate the cancer development and the level of hnRNP G expression, we performed an immunohistochemistry staining of hnRNP G in normal, premalignant and malignant human oral tissues. Moreover, we examined the entire coding regions of hnRNP G from selected samples to understand the cause of the alterations of the gene expression. The expression of hnRNP G was notably decreased or completely abolished in 80% of premalignant-dysplastic and malignant oral epithelial tissues, whereas 100% of normal and 90% of hyperplastic non-dysplastic epithelium showed high level of hnRNP G in the nucleus of the basal cell layers. Approximately 80% of HOSCC lacking the expression of hnRNP G showed genetic alteration in hnRNP G, i.e., point mutation and exonic deletion. This study suggest that genetic alterations and aberrant expression of hnRNP G occurring during oral carcinogenesis might be useful markers for the early detection of human oral cancer. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840245      PMCID: PMC3199327          DOI: 10.1016/j.oraloncology.2011.07.012

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  20 in total

1.  hnRNP G: sequence and characterization of a glycosylated RNA-binding protein.

Authors:  M Soulard; V Della Valle; M C Siomi; S Piñol-Roma; P Codogno; C Bauvy; M Bellini; J C Lacroix; G Monod; G Dreyfuss
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

Review 2.  hnRNP proteins and the biogenesis of mRNA.

Authors:  G Dreyfuss; M J Matunis; S Piñol-Roma; C G Burd
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

3.  Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer.

Authors:  Zhaohui Feng; Wenwei Hu; James X Chen; Annie Pao; Haiying Li; William Rom; Mien-Chie Hung; Moon-shong Tang
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

4.  hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung.

Authors:  Shulin Wu; Masami Sato; Chiaki Endo; Akira Sakurada; Boming Dong; Hirokazu Aikawa; Yan Chen; Yoshinori Okada; Yuhji Matsumura; Eisaburo Sueoka; Takashi Kondo
Journal:  Lung Cancer       Date:  2003-08       Impact factor: 5.705

5.  HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding.

Authors:  M Talat Nasim; Tatyana K Chernova; Hasnin M Chowdhury; Bai-Gong Yue; Ian C Eperon
Journal:  Hum Mol Genet       Date:  2003-06-01       Impact factor: 6.150

6.  hnRNP G elicits tumor-suppressive activity in part by upregulating the expression of Txnip.

Authors:  Ki-Hyuk Shin; Reuben H Kim; Roy H Kim; Mo K Kang; No-Hee Park
Journal:  Biochem Biophys Res Commun       Date:  2008-06-09       Impact factor: 3.575

7.  Isolation of the heterogeneous nuclear RNA-ribonucleoprotein complex (hnRNP): a unique supramolecular assembly.

Authors:  Y D Choi; G Dreyfuss
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  A novel 43-kDa glycoprotein is detected in the nucleus of mammalian cells by autoantibodies from dogs with autoimmune disorders.

Authors:  M Soulard; J P Barque; V Della Valle; D Hernandez-Verdun; C Masson; F Danon; C J Larsen
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

9.  Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection.

Authors:  Galina V Glazko; Eugene V Koonin; Igor B Rogozin
Journal:  Biochim Biophys Acta       Date:  2004-08-12

10.  Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis.

Authors:  S Matsuyama; Y Goto; N Sueoka; Y Ohkura; Y Tanaka; K Nakachi; E Sueoka
Journal:  Jpn J Cancer Res       Date:  2000-06
View more
  6 in total

1.  Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.

Authors:  Chang-Ryul Lee; Sung Hee Lee; Nicole Kristina Rigas; Reuben H Kim; Mo K Kang; No-Hee Park; Ki-Hyuk Shin
Journal:  Carcinogenesis       Date:  2015-12-08       Impact factor: 4.944

2.  Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells.

Authors:  Liancheng Zhu; Zhenhua Hu; Juanjuan Liu; Jian Gao; Bei Lin
Journal:  Med Oncol       Date:  2014-12-11       Impact factor: 3.064

3.  Secondary Structural Model of MALAT1 Becomes Unstructured in Chronic Myeloid Leukemia and Undergoes Structural Rearrangement in Cervical Cancer.

Authors:  Matthew C Wang; Phillip J McCown; Grace E Schiefelbein; Jessica A Brown
Journal:  Noncoding RNA       Date:  2021-01-13

4.  hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.

Authors:  Chengyu Hao; Yunji Zheng; Johanna Jönsson; Xiaoxu Cui; Haoran Yu; Chengjun Wu; Naoko Kajitani; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

5.  Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation.

Authors:  Ahmed Moursy; Frédéric H-T Allain; Antoine Cléry
Journal:  Nucleic Acids Res       Date:  2014-04-01       Impact factor: 16.971

6.  Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.

Authors:  Sung Hee Lee; Nicole Kristina Rigas; Chang-Ryul Lee; April Bang; Sonal Srikanth; Yousang Gwack; Mo K Kang; Reuben H Kim; No-Hee Park; Ki-Hyuk Shin
Journal:  Oncotarget       Date:  2016-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.